Matrix Metalloproteinase-9 in Lung Remodeling
Top Cited Papers
- 1 January 2003
- journal article
- review article
- Published by American Thoracic Society in American Journal of Respiratory Cell and Molecular Biology
- Vol. 28 (1) , 12-24
- https://doi.org/10.1165/rcmb.2002-0166tr
Abstract
Matrix metalloproteinase (MMP)-9 (Gelatinase B, 92-kD type IV collagenase, EC 3.4.24.35) is an MMP that is present in low quantities in the healthy adult lung, but much more abundant in several lung diseases, including asthma, idiopathic pulmonary fibrosis (IPF), and chronic obstructive pulmonary disease (COPD). Despite numerous reports of MMP-9 in these and other lung diseases, whether MMP-9 is causal in lung remodeling or part of the inflammatory and reparative response remains to be determined. Many intrinsic lung cells can be stimulated to produce MMP-9, but much of the information regarding MMP-9 in the lung deals with MMP-9 from inflammatory cells. The multiple locations and cell types producing MMP-9 are consistent with multiple functions in different microenvironments. In addition to digestion of structural proteins and antiproteases, MMP-9 can modify cellular function by regulation of cytokines and matrix-bound growth factors. Determining the role of MMP-9 in health and disease will be important, because broad spectrum and specific inhibitors will soon be available to enable conversion of the bench knowledge to bedside practice. This review addresses the current understanding of MMP-9 in human asthma, IPF, and COPD, and in animal models of these conditions.Keywords
This publication has 150 references indexed in Scilit:
- New functions for the matrix metalloproteinases in cancer progressionNature Reviews Cancer, 2002
- Genetic Polymorphism in Matrix Metalloproteinase-9 and Pulmonary EmphysemaBiochemical and Biophysical Research Communications, 2001
- In Vivo Localization of Gelatinases (MMP-2 and -9) by in Situ Zymography with a Selective Gelatinase InhibitorBiochemical and Biophysical Research Communications, 2001
- Characteristics of the Inflammatory Response in Bronchial Lavage Fluids from Patients with Status asthmaticusInternational Archives of Allergy and Immunology, 2001
- Gelatinase B Is Required for Alveolar Bronchiolization after Intratracheal BleomycinThe American Journal of Pathology, 2000
- Inhaled corticosteroids decrease subepithelial collagen deposition by modulation of the balance between matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in asthma☆☆☆Journal of Allergy and Clinical Immunology, 1999
- Gelatinase B–deficient Mice Are Resistant to Experimental Bullous PemphigoidThe Journal of Experimental Medicine, 1998
- Elevated levels of matrix metalloproteinases in bronchoalveolar lavage fluid of emphysematous patientsThorax, 1997
- A Possible Role for MMP-2 and MMP-9 in the Migration of Primate Arterial Smooth Muscle Cells through Native MatrixAnnals of the New York Academy of Sciences, 1994
- Secretion of gelatinases and tissue inhibitors of metalloproteinases by human lung cancer cell lines and revertant cell lines: Not an invariant correlation with metastasisInternational Journal of Cancer, 1992